Drug Patent Expirations in June 2014

Drug Patent Expirations in June 2014

Drug Patent Expirations for June 2014

Tradename Applicant Generic Name Patent Number Patent Expiration
BETOPTIC PILO Alcon betaxolol hydrochloride; pilocarpine hydrochloride 5,635,172 Jun 3, 2014
LOCOID LIPOCREAM Precision Dermat hydrocortisone butyrate 5,635,497 Jun 3, 2014
ATACAND HCT Astrazeneca candesartan cilexetil; hydrochlorothiazide 5,958,961 Jun 6, 2014
NEVANAC Alcon Pharms Ltd nepafenac 5,475,034 Jun 6, 2014
ILEVRO Alcon Res Ltd nepafenac 5,475,034 Jun 6, 2014
EDARBI Arbor Pharms Ireland azilsartan kamedoxomil 5,958,961 Jun 6, 2014
TAZORAC Allergan tazarotene 6,258,830 Jun 7, 2014
TAZORAC Allergan tazarotene 5,914,334 Jun 7, 2014
ACTONEL WITH CALCIUM (COPACKAGED) Warner Chilcott calcium carbonate; risedronate sodium 5,583,122*PED Jun 10, 2014
NAPRELAN Almatica Pharma Inc naproxen sodium 5,637,320 Jun 10, 2014
FROVA Endo Pharms frovatriptan succinate 5,637,611 Jun 10, 2014
ACTONEL Warner Chilcott Llc risedronate sodium 5,583,122*PED Jun 10, 2014
ATELVIA Warner Chilcott Llc risedronate sodium 5,583,122*PED Jun 10, 2014
XELODA Hoffmann La Roche capecitabine 5,472,949*PED Jun 14, 2014
HUMALOG MIX 50/50 KWIKPEN Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,461,031 Jun 16, 2014
HUMALOG PEN Lilly insulin lispro recombinant 5,474,978 Jun 16, 2014
HUMALOG MIX 50/50 KWIKPEN Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,747,642 Jun 16, 2014
HUMALOG Lilly insulin lispro recombinant 5,474,978 Jun 16, 2014
HUMALOG MIX 75/25 Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,474,978 Jun 16, 2014
HUMALOG MIX 50/50 Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,461,031 Jun 16, 2014
HUMALOG MIX 75/25 KWIKPEN Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,461,031 Jun 16, 2014
HUMALOG MIX 50/50 Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,747,642 Jun 16, 2014
HUMALOG MIX 75/25 KWIKPEN Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,747,642 Jun 16, 2014
HUMALOG MIX 50/50 KWIKPEN Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,474,978 Jun 16, 2014
HUMALOG MIX 75/25 Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,461,031 Jun 16, 2014
HUMALOG KWIKPEN Lilly insulin lispro recombinant 5,474,978 Jun 16, 2014
HUMALOG MIX 75/25 Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,747,642 Jun 16, 2014
HUMALOG MIX 50/50 Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,474,978 Jun 16, 2014
HUMALOG MIX 75/25 KWIKPEN Lilly insulin lispro protamine recombinant; insulin lispro recombinant 5,474,978 Jun 16, 2014
SOLARAZE Fougera Pharms diclofenac sodium 5,639,738 Jun 17, 2014
SOLARAZE Fougera Pharms diclofenac sodium 5,929,048 Jun 17, 2014
IMAGENT Imcor Pharms Co dimyristoyl lecithin; perflexane 5,639,443 Jun 17, 2014
SOLARAZE Fougera Pharms diclofenac sodium 5,852,002 Jun 17, 2014
MARQIBO KIT Talon Therap vincristine sulfate 5,741,516 Jun 20, 2014
MARQIBO KIT Talon Therap vincristine sulfate 5,814,335 Jun 20, 2014
MARQIBO KIT Talon Therap vincristine sulfate 5,543,152 Jun 20, 2014
ZEMPLAR Abbvie paricalcitol 5,587,497*PED Jun 24, 2014
YAZ Bayer Hlthcare drospirenone; ethinyl estradiol RE37838 Jun 30, 2014
BEYAZ Bayer Hlthcare drospirenone; ethinyl estradiol; levomefolate calcium RE37564 Jun 30, 2014
YAZ Bayer Hlthcare drospirenone; ethinyl estradiol RE38253 Jun 30, 2014
BEYAZ Bayer Hlthcare drospirenone; ethinyl estradiol; levomefolate calcium RE37838 Jun 30, 2014
ACOVA Pfizer argatroban 5,214,052 Jun 30, 2014
YAZ Bayer Hlthcare drospirenone; ethinyl estradiol RE43916 Jun 30, 2014
BEYAZ Bayer Hlthcare drospirenone; ethinyl estradiol; levomefolate calcium RE43916 Jun 30, 2014
YAZ Bayer Hlthcare drospirenone; ethinyl estradiol RE37564 Jun 30, 2014
BEYAZ Bayer Hlthcare drospirenone; ethinyl estradiol; levomefolate calcium RE38253 Jun 30, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.